Tags

Type your tag names separated by a space and hit enter

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Sci Rep. 2020 Nov 11; 10(1):19870.SR

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Links

PMC Free PDF

Authors+Show Affiliations

Luszczak S
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Simpson BS
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Stopka-Farooqui U
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Sathyadevan VK
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Echeverria LMC
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Kumar C
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Costa H
2Research Department of Pathology, University College London, London, UK.
Haider A
2Research Department of Pathology, University College London, London, UK.
Freeman A
2Research Department of Pathology, University College London, London, UK.
Jameson C
2Research Department of Pathology, University College London, London, UK.
Ratynska M
2Research Department of Pathology, University College London, London, UK.
Ben-Salha I
2Research Department of Pathology, University College London, London, UK.
Sridhar A
Department of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK.
Shaw G
Department of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK.
Kelly JD
Department of Uro‑Oncology, UCLH NHS Foundation Trust, London, UK.
Pye H
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Gately KA
Trinity Translational Medicine Institute, St. James's Hospital Dublin, Dublin 8, Ireland.
Whitaker HC
Molecular Diagnostics and Therapeutics Group, University College London, London, UK.
Heavey S
Molecular Diagnostics and Therapeutics Group, University College London, London, UK. s.heavey@ucl.ac.uk.

Pub Type(s)

Published Erratum

Language

eng

PubMed ID

33177621

Citation

Luszczak, Sabina, et al. "Author Correction: Co-targeting PIM and PI3K/mTOR Using Multikinase Inhibitor AUM302 and a Combination of AZD-1208 and BEZ235 in Prostate Cancer." Scientific Reports, vol. 10, no. 1, 2020, p. 19870.
Luszczak S, Simpson BS, Stopka-Farooqui U, et al. Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. Sci Rep. 2020;10(1):19870.
Luszczak, S., Simpson, B. S., Stopka-Farooqui, U., Sathyadevan, V. K., Echeverria, L. M. C., Kumar, C., Costa, H., Haider, A., Freeman, A., Jameson, C., Ratynska, M., Ben-Salha, I., Sridhar, A., Shaw, G., Kelly, J. D., Pye, H., Gately, K. A., Whitaker, H. C., & Heavey, S. (2020). Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. Scientific Reports, 10(1), 19870. https://doi.org/10.1038/s41598-020-76679-x
Luszczak S, et al. Author Correction: Co-targeting PIM and PI3K/mTOR Using Multikinase Inhibitor AUM302 and a Combination of AZD-1208 and BEZ235 in Prostate Cancer. Sci Rep. 2020 Nov 11;10(1):19870. PubMed PMID: 33177621.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer. AU - Luszczak,Sabina, AU - Simpson,Benjamin S, AU - Stopka-Farooqui,Urszula, AU - Sathyadevan,Vignesh Krishna, AU - Echeverria,Lina M Carmona, AU - Kumar,Christopher, AU - Costa,Helena, AU - Haider,Aiman, AU - Freeman,Alex, AU - Jameson,Charles, AU - Ratynska,Marzena, AU - Ben-Salha,Imen, AU - Sridhar,Ashwin, AU - Shaw,Greg, AU - Kelly,John D, AU - Pye,Hayley, AU - Gately,Kathy A, AU - Whitaker,Hayley C, AU - Heavey,Susan, Y1 - 2020/11/11/ PY - 2020/11/12/entrez PY - 2020/11/13/pubmed PY - 2020/11/13/medline SP - 19870 EP - 19870 JF - Scientific reports JO - Sci Rep VL - 10 IS - 1 N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper. SN - 2045-2322 UR - https://www.unboundmedicine.com/medline/citation/33177621/Author_Correction:_Co_targeting_PIM_and_PI3K/mTOR_using_multikinase_inhibitor_AUM302_and_a_combination_of_AZD_1208_and_BEZ235_in_prostate_cancer_ DB - PRIME DP - Unbound Medicine ER -